
In late January 2020, as a new virus infected hundreds of people each day in the Chinese city of Wuhan, scientists at the Galveston National Laboratory in Texas urgently sought access to the pathogen to start their own research.
They turned to the Wuhan Institute of Virology (WIV), whose scientists they had helped to train, hoping they could execute a swift “material transfer agreement” to get the coronavirus to their labs.
Already a subscriber? Log in
Subscribe now and get 30% off The Star Yearly Plan
Cancel anytime. Ad-free. Unlimited access with perks.